Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

Current AHA guidelines call for healthy Americans to bring LDL below 100 milligrams per deciliter (mg/dL) of blood, while those who’ve had a heart attack or stroke are encouraged to drop LDL at least ...

Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals' risk of developing liver ...

In some cases, these non-pharmaceutical methods ... “There are certain foods that can help lower cholesterol levels, but they are not a substitute for statins. For example, phytosterols and ...

Trials of Intensive Statin Therapy in Stable Coronary ... MIRACL = Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering; NSTEMI = Non-ST elevation acute myocardial infarction ...

Statins are the most widely prescribed, cholesterol-lowering drugs in the world. Despite the expiration of their patents, revenue for statins is expected to rise, with total sales on track to reach an ...

Yet in 2009, pediatricians wrote children in the U.S. at least 2.8 million prescriptions for drugs to lower cholesterol; nearly 2.3 million of them were for statins. (not including prescriptions ...

The trial evaluated the efficacy of obicetrapib, an oral, non-statin cholesterol-lowering medication, in patients with cardiovascular disease and high low-density lipoprotein cholesterol (LDL-C ...

non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently ...

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...